Kiromic BioPharma, Inc (KRBP)

Etorro trading 970x250
Kiromic BioPharma, Inc (KRBP) Logo

About Kiromic BioPharma, Inc

Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. Its product portfolio include ALEXIS AIDT-1, an allogenic CAR cell product candidate targeting AIDT-1; ALEXIS AIDT-2 EOC, an allogenic CAR cell product candidate targeting AIDT-2; ALEXIS AIDT-2 MPM (malignant pleural mesothelioma), an allogenic CAR/NKT-Like cell product candidate targeting AIDT-2; and PD-1-AR, a check point inhibitor for solid tumors, as well as oral healthcare products, such as mouthwash. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Address: 7707 Fannin, Houston, TX, United States, 77054

Kiromic BioPharma, Inc News and around…

Latest news about Kiromic BioPharma, Inc (KRBP) common stock and company :

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
11 Oct, 2021 FinancialContent

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The ...

Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers
11 Oct, 2021 FinancialContent

Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital

35 Biggest Movers From Friday
11 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s ...

28 Stocks Moving In Friday's Mid-Day Session
08 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma Announces Chief Financial Officer Transition
06 Oct, 2021 FinancialContent

Kiromic BioPharma Announces Chief Financial Officer Transition

12 Health Care Stocks Moving In Monday's After-Market Session
13 Sep, 2021 FinancialContent

Gainers aTyr Pharma (NASDAQ:LIFE) stock increased by 13.77% to $10.41 during Monday's after-market session. Trading volume for this ...

3 Penny Stocks Insiders Are Buying
13 Sep, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

48 Biggest Movers From Yesterday
10 Sep, 2021 FinancialContent

Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and ...

12 Health Care Stocks Moving In Thursday's Intraday Session
09 Sep, 2021 FinancialContent

Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. ...

35 Stocks Moving In Thursday's Mid-Day Session
09 Sep, 2021 FinancialContent

Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation ...

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
20 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights
13 Aug, 2021 FinancialContent

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights

Kiroma BioPharma, Inc. Investors: Company Investigated by the Portnoy Law Firm
29 Jul, 2021 FinancialContent

Investors can contact the law firm at no cost to learn more about recovering their losses

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

62 Biggest Movers From Yesterday
28 Jul, 2021 FinancialContent

Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued ...

44 Stocks Moving In Tuesday's Mid-Day Session
27 Jul, 2021 FinancialContent

Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement ...

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
27 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

34 Stocks Moving in Tuesday's Pre-Market Session
27 Jul, 2021 FinancialContent

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced ...

Kiromic Stock Surges On Acquisition Of InSilico Solutions For Undisclosed Sum
27 Jul, 2021 FinancialContent

Kiromic Biopharma Inc(NASDAQ: KRBP) acquiredInSilico Solutions, a bioinformatics and artificial intelligence software ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kiromic BioPharma, Inc. - KRBP
27 Jul, 2021 FinancialContent
Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors
26 Jul, 2021 FinancialContent

Kiromic announces the acquisition of InSilico Solutions leveraging on Bioinformatics and Artificial Intelligence to advance clinical development

Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors
26 Jul, 2021 Yahoo! Finance

HOUSTON, July 26, 2021--Kiromic announces the acquisition of InSilico Solutions leveraging on Bioinformatics and Artificial Intelligence to advance clinical development

Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Kiromic BioPharma, Inc. (NASDAQ:KRBP) Investigation
23 Jul, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / July 23, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kiromic BioPharma, Inc. ('Kiromic" or 'the Company') (NASDAQ:KRBP).

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
20 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Kiromic BioPharma, Inc. (KRBP) Investigation
19 Jul, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / July 19, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kiromic BioPharma, Inc. ('Kiromic" or 'the Company') (NASDAQ:KRBP).

50 Biggest Movers From Friday
19 Jul, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 41.2% to settle at $7.10 on Friday. Blue Foundry Bancorp (NASDAQ: ...

Kiromic BioPharma Provides Update on IND Filings on its Off-the-Shelf, Allogeneic CAR-T for Solid Tumors
16 Jul, 2021 FinancialContent

Kiromic BioPharma Provides Update on IND Filings on its Off-the-Shelf, Allogeneic CAR-T for Solid Tumors

Kiromic BioPharma, Inc (KRBP) is a NASDAQ Common Stock listed in , ,

970x250